top of page

Paul Little, PhD CChem FRSC



Paul Little has 20+ years operational and management experience in biotech and is an Operating Partner at Lundbeckfonden BioCapital. Paul joined the biotech investment unit in 2016. Paul is a member of the board of Folium Science and Fellow of the Royal Society of Chemistry.


Prior to joining Vesper Bio, Paul worked at 7TM Pharma, Orphazyme and Insusense and has taken interim management roles in NMD Pharma and CytoKi.

bottom of page